Bekhealth

BEKhealth (BEKHealth Corporation) is an AI-powered clinical intelligence company that converts electronic health record data into insight for clinical research and real-world evidence generation. Its products are BEKplatform, a chart abstraction and patient-matching engine, and BEKnetwork, a connected network of research sites and healthcare organizations. The platform ingests structured fields alongside unstructured content such as physician notes, PDFs, lab and pathology reports and handwritten records, and builds a synthesized longitudinal patient graph that can be queried for cohort building, feasibility reporting and protocol-eligible candidate identification.

The company positions the same longitudinal record behind two use cases: trial operations (feasibility response, site selection, patient identification and enrollment) and evidence generation (longitudinal, EHR-derived real-world datasets for observational research, regulatory submissions, post-market evidence and market access). Data is described as refreshed daily with traceability back to source records. Featured therapeutic areas include dermatology (psoriasis, atopic dermatitis, acne, hidradenitis suppurativa, alopecia) and cardiometabolic conditions (type 2 diabetes, obesity, chronic kidney disease, heart failure, ASCVD, hypertension).

Alongside software, BEKhealth provides research nurses and clinical support staff to help customers build feasibility reports and run identification workflows, positioning the offering as a combination of AI tooling and hands-on services rather than self-service software alone.

Founding story

The company states it was built on the premise that data created in everyday patient care should do more to advance research, inform decisions and help patients access new opportunities, and that its approach starts in the reality of community-based patient care.

Business model

BEKhealth sells access to BEKplatform and to data derived from BEKnetwork. Site networks and healthcare organizations connect their EHR data to the platform to respond to sponsor feasibility requests and win more studies, while sponsors and CROs buy patient-matching, site selection and curated longitudinal real-world datasets. The company publishes platform pricing and ROI information for network customers and pairs the software with clinical support staff.

Platform access for site networks and research sites, together with data and services sold to sponsors and CROs; the company markets pricing and ROI options for platform customers and describes new revenue streams for networks that contribute EHR data to BEKnetwork.

Traction

Company materials cite a network spanning more than 30 million patient records, 200+ research sites and healthcare organizations, 20,000 participating clinicians and 1,000+ trials. The February 2025 financing announcement followed customer base expansion during 2024 across a list of named research networks and site organizations. In a joint deployment with Delfa, the first shared client is described as having 200 clinically eligible patients identified and 8 patients pre-screened and scheduled within 60 minutes of implementation.

Latest developments

In February 2025 BEKhealth announced a $4 million financing co-led by Hatteras Venture Partners and Boston Millennia Partners, with participation from existing investors Excelerate Health Ventures and Martin Ventures and new investors RTI International and WakeMed Innovation Fund, intended to expand its customer base and product offering. RTI Health Solutions described the investment as a collaboration to combine real-time real-world data with patient-provided insights. The company has also expanded its leadership team with executives from TriNetX, Deep 6 AI, Verana Health, PicnicHealth, Veeva and Citeline, and has launched a partnership with Delfa on AI-powered enrollment.